Navigation Links
Internal Groups are Valuable Sources for Pharmaceutical Competitive Intelligence Function
Date:9/13/2011

CHAPEL HILL, N.C., Sept. 13, 2011 /PRNewswire/ -- Pharmaceutical Competitive Intelligence functions look to internal colleagues and departments to unearth critical insights. Internal groups most often receiving the highest value ratings as information sources are Medical Affairs and Medical Science Liaisons.

More than 80 percent of companies currently reach out to Medical Affairs for valuable competitive intelligence. However, nearly one-third of companies do not tap their Medical Science Liaisons for information, according to "Best Practices in Competitive Intelligence: Policies & Guidelines that Reduce Corporate Risks," a primary research study conducted by Best Practices, LLC.

Download a complimentary white paper at http://www3.best-in-class.com/rr1116.htm that includes selected best practices drawn from extensive primary research with competitive intelligence leaders from 22 different biopharmaceutical companies.

Key insights include:

  • Benchmarked companies use an array of external sources to collect competitive intelligence. Medical congresses are the most used external CI source, and clinical trial investigators the highest rated. Third-party CI vendors rank second in both use and value.
  • The primary source that vendors go to is Key Opinion Leaders. Other top targets are medical congresses and competitor companies.

The full 52-page report contains more than 120 benchmark metrics and 16 executive narratives, providing executives with benchmarks of world-class companies for optimizing CI operations and working with the Legal department to develop policies as well as insights into the best practices for collection, use and sources of primary data - including employment of third party vendors for primary data collection.

For more information on this study and other recent primary research studies, contact us at 919.403.0251 or at bestpractices@best-in-class.com.  

BEST PRACTICES, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for more than 17 years; our clients include 48 out of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Building Support for a New Product Through Effective Internal Disease State Communication
2. Pharmaceutical Internal Communications Function Morphs to Address Corporate Priorities
3. Internal Fixation Systems, Inc. Announces Form S-1 Declared Effective by SEC and Anticipated Quotation for Trading on OTCQB
4. Maximizing the Potential of Internal and External Communications Groups
5. Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan
6. SyncMedical Receives ANVISA Regulatory Approval to Offer Spine and Internal Medicine Products in Brazil
7. Toriseva Law and Karon & Dalimonte LLP: Archives of Internal Medicine Article Faults Manufacturers of IVC Filters
8. Corporate Affairs Role in Internal and External Relationships Key to Organizational Success
9. International Medical News Group Relaunches Internal Medicine News Digital Network and Hospitalist News Digital Network
10. Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine
11. Using Internal Communications to Help Build a Credible External Message Regarding New Pharmaceutical Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... April 21, 2017 Halo Labs announces the ... particle analysis system called the Horizon at PEGS 2017 ... The new system analyzes sub visible particulate matter in ... particle screening as early as candidate selection and pre-formulation. ... biopharma contract research organization Elion Labs for ...
(Date:4/20/2017)... 20, 2017  Zimmer Biomet Holdings, Inc. (NYSE and ... announced that it will be participating in the Deutsche ... InterContinental Hotel in Boston, Massachusetts ... at 11:20 a.m. Eastern Time. A live ... Biomet,s Investor Relations website at http://investor.zimmerbiomet.com .  The ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... As Spring reignites vigilance ... research related to Zika virus during pregnancy, as well as other prenatal exposures ... science. , The Teratology Society is an international and multidisciplinary ...
(Date:4/25/2017)... ... ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace – from ... be heartened by the industry’s current surge. But another thing that unifies them is ... At last they can simply, safely and effectively end their aroma anguish thanks to ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... of predictive analytics to its patient care management module. Using this new feature, ... a patient has been initiated on continuous positive airway pressure (CPAP), oral, or ...
(Date:4/25/2017)... , ... April 25, 2017 , ... There is no ... Hospital, according to a special report in the May issue of Consumer Reports focused ... highest quality ranking for results achieved during and after coronary bypass and aortic valve ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, ... its strategic partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a ... effective management of complex spine deformity cases, particularly in children. , GSO’s focus ...
Breaking Medicine News(10 mins):